Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · October 01, 2023

Locoregional Radiotherapy Improves Survival Outcomes in Patients With De Novo Metastatic Nasopharyngeal Carcinoma Receiving Chemoimmunotherapy



Additional Info

Locoregional radiotherapy improves survival outcomes in de novo metastatic nasopharyngeal carcinoma treated with chemoimmunotherapy
ESMO Open 2023 Sep 01;8(5)101629, YJ Hu, TZ Lu, H Zhang, M Fang, BJ Chen, QJ Guo, SJ Lin, P Feng, Y Wang, TC Jiang, XC Gong, JJ Pan, JG Li, YF Xia

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading